Hyperspectral Imaging for the Detection of Glioblastoma Tumor Cells in H&E Slides Using Convolutional Neural Networks
Overview
Authors
Affiliations
Hyperspectral imaging (HSI) technology has demonstrated potential to provide useful information about the chemical composition of tissue and its morphological features in a single image modality. Deep learning (DL) techniques have demonstrated the ability of automatic feature extraction from data for a successful classification. In this study, we exploit HSI and DL for the automatic differentiation of glioblastoma (GB) and non-tumor tissue on hematoxylin and eosin (H&E) stained histological slides of human brain tissue. GB detection is a challenging application, showing high heterogeneity in the cellular morphology across different patients. We employed an HSI microscope, with a spectral range from 400 to 1000 nm, to collect 517 HS cubes from 13 GB patients using 20× magnification. Using a convolutional neural network (CNN), we were able to automatically detect GB within the pathological slides, achieving average sensitivity and specificity values of 88% and 77%, respectively, representing an improvement of 7% and 8% respectively, as compared to the results obtained using RGB (red, green, and blue) images. This study demonstrates that the combination of hyperspectral microscopic imaging and deep learning is a promising tool for future computational pathologies.
Lai C, Karmakar R, Mukundan A, Natarajan R, Lu S, Wang C APL Bioeng. 2024; 8(4):041504.
PMID: 39660034 PMC: 11629177. DOI: 10.1063/5.0240444.
Evolution of Molecular Biomarkers and Precision Molecular Therapeutic Strategies in Glioblastoma.
Jacome M, Wu Q, Pina Y, Etame A Cancers (Basel). 2024; 16(21).
PMID: 39518074 PMC: 11544870. DOI: 10.3390/cancers16213635.
Leung J, Karmakar R, Mukundan A, Lin W, Anwar F, Wang H Diagnostics (Basel). 2024; 14(17).
PMID: 39272675 PMC: 11394276. DOI: 10.3390/diagnostics14171888.
Verma R, Alban T, Parthasarathy P, Mokhtari M, Toro Castano P, Cohen M Sci Adv. 2024; 10(34):eadi0302.
PMID: 39178259 PMC: 11343024. DOI: 10.1126/sciadv.adi0302.
Cruz-Guerrero I, Campos-Delgado D, Mejia-Rodriguez A, Leon R, Ortega S, Fabelo H Healthc Technol Lett. 2024; 11(4):240-251.
PMID: 39100499 PMC: 11294933. DOI: 10.1049/htl2.12084.